 <h1>Onivyde Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>irinotecan liposomal</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about irinotecan liposomal. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Onivyde.</p><h2>In Summary</h2><p><b>Common side effects of Onivyde include:</b> fever.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to irinotecan liposomal: intravenous solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Solution)</p><p>Fatal neutropenic sepsis has been reported with irinotecan liposome therapy. Life-threatening neutropenia, life-threatening neutropenic fever or sepsis, and severe diarrhea has been reported with irinotecan liposome therapy in combination with fluorouracil and leucovorin. Monitor blood cell counts periodically. Withhold treatment for absolute neutrophil count below 1500/mm(3), neutropenic fever. Severe diarrhea has been reported. Withhold treatment for grade 2 or higher diarrhea. Administer atropine for early diarrhea and administer loperamide for late diarrhea. Do not administer to patients with bowel obstruction.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, irinotecan liposomal (the active ingredient contained in Onivyde) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking irinotecan liposomal:</p><p>
<i>More common</i>
</p><ul>
<li>Confusion</li>
<li>decreased urination</li>
<li>diarrhea (severe)</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fever</li>
<li>lightheadedness</li>
<li>rapid breathing</li>
<li>sunken eyes</li>
<li>thirst</li>
<li>unusual tiredness or weakness</li>
<li>wrinkled skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>fast heartbeat</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>rapid, shallow breathing</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>sore throat</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty with breathing or swallowing</li>
<li>hives, itching, or skin rash</li>
<li>nausea</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>reddening of the skin, especially around the ears</li>
<li>tightness in the chest</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of irinotecan liposomal may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>hair loss or thinning of the hair</li>
<li>lack or loss of strength</li>
<li>vomiting</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>feeling of warmth</li>
<li>increased sweating</li>
<li>runny nose</li>
<li>sneezing</li>
<li>stuffy nose</li>
<li>tearing of the eyes</li>
<li>watering of the mouth</li>
<li>weakness</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to irinotecan liposomal: intravenous dispersion</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (70%), nausea (61%), vomiting (54%), abdominal pain (34%), constipation (18%), stomatitis, mucosal inflammation</p>
<p><b>Common</b> (1% to 10%): Gastroenteritis, oral candidiasis, colitis, hemorrhoids</p>
<p><b>Uncommon</b> (0.1% to 1%): Esophagitis, proctitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (22%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash maculopapular, nail discoloration<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (33%), neutropenia (15%), leukopenia, thrombocytopenia</p>
<p><b>Common</b> (1% to 10%): Lymphopenia, febrile neutropenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Biliary sepsis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hypoalbuminemia, increased bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, increased international normalized ratio<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (49%), weight loss (20%), hypokalemia, hypomagnesemia, dehydration</p>
<p><b>Common</b> (1% to 10%): Hypoglycemia, hyponatremia, hypophosphatemia, dehydration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (12%)</p>
<p><b>Common</b> (1% to 10%): Cholinergic syndrome, dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (37%), asthenia (24%), pyrexia (20%), enema peripheral (19%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Acute renal failure<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Septic shock, sepsis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia, pulmonary embolism, embolism, dyspnea, dysphonia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, deep vein thrombosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Onivyde (irinotecan liposomal)." Merrimack Pharmaceuticals, Cambridge, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Onivyde (irinotecan liposomal)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Onivyde &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Pancreatic Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to irinotecan liposomal: intravenous dispersion</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (70%), nausea (61%), vomiting (54%), abdominal pain (34%), constipation (18%), stomatitis, mucosal inflammation</p><p><b>Common</b> (1% to 10%): Gastroenteritis, oral candidiasis, colitis, hemorrhoids</p><p><b>Uncommon</b> (0.1% to 1%): Esophagitis, proctitis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (22%)</p><p><b>Uncommon</b> (0.1% to 1%): Rash maculopapular, nail discoloration<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (33%), neutropenia (15%), leukopenia, thrombocytopenia</p><p><b>Common</b> (1% to 10%): Lymphopenia, febrile neutropenia</p><p><b>Uncommon</b> (0.1% to 1%): Biliary sepsis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hypoalbuminemia, increased bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, increased international normalized ratio<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (49%), weight loss (20%), hypokalemia, hypomagnesemia, dehydration</p><p><b>Common</b> (1% to 10%): Hypoglycemia, hyponatremia, hypophosphatemia, dehydration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (12%)</p><p><b>Common</b> (1% to 10%): Cholinergic syndrome, dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (37%), asthenia (24%), pyrexia (20%), enema peripheral (19%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Acute renal failure<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Septic shock, sepsis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia, pulmonary embolism, embolism, dyspnea, dysphonia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, deep vein thrombosis</p><p><b>Uncommon</b> (0.1% to 1%): Thrombosis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Onivyde (irinotecan liposomal)." Merrimack Pharmaceuticals, Cambridge, MA. </p><h2>More about Onivyde (irinotecan liposomal)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Onivyde &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pancreatic Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>